The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 3
  • 1
    Johnson, Paul, Mr.
    Director born in December 1972
    Individual (8 offsprings)
    Officer
    2017-05-16 ~ now
    OF - Director → CIF 0
  • 2
    Anwar, Rauf
    Company Director born in May 1982
    Individual (3 offsprings)
    Officer
    2024-01-01 ~ now
    OF - Director → CIF 0
  • 3
    1st Floor Marlow International, Parkway, Marlow, England
    Active Corporate (3 parents, 5 offsprings)
    Person with significant control
    2016-08-23 ~ now
    PE - Ownership of shares – 75% or more → CIF 0
    PE - Ownership of voting rights - 75% or more → CIF 0
    PE - Right to appoint or remove directors → CIF 0
Ceased 14
  • 1
    Shindler, Martin, Mr.
    Director born in October 1961
    Individual
    Officer
    2018-03-13 ~ 2018-12-20
    OF - Director → CIF 0
  • 2
    Nelligan, Tom
    Individual
    Officer
    2016-08-26 ~ 2017-10-13
    OF - Secretary → CIF 0
  • 3
    Boorsma, Marco, Dr
    Director born in November 1974
    Individual (2 offsprings)
    Officer
    2016-02-10 ~ 2016-09-26
    OF - Director → CIF 0
  • 4
    Haran, Patricia Maria
    Individual (8 offsprings)
    Officer
    2018-02-19 ~ 2021-07-05
    OF - Secretary → CIF 0
  • 5
    Iglesias-fernandez, Luis
    Director born in July 1961
    Individual
    Officer
    2016-08-26 ~ 2017-03-31
    OF - Director → CIF 0
  • 6
    Subramaniam, Somasundaram
    Venture Capital born in August 1954
    Individual (10 offsprings)
    Officer
    2014-10-24 ~ 2016-08-26
    OF - Director → CIF 0
  • 7
    Hong, Jason
    Director born in November 1975
    Individual
    Officer
    2015-02-09 ~ 2016-08-26
    OF - Director → CIF 0
  • 8
    Muhle, Gerhard William Franz
    Director born in August 1971
    Individual
    Officer
    2016-08-26 ~ 2017-05-31
    OF - Director → CIF 0
  • 9
    Horn, David Evan, Mr.
    Director born in June 1978
    Individual
    Officer
    2018-03-13 ~ 2018-12-20
    OF - Director → CIF 0
  • 10
    Astle, Christopher John
    Director born in July 1979
    Individual
    Officer
    2016-08-26 ~ 2017-05-16
    OF - Director → CIF 0
  • 11
    Massey, Nicola
    Director born in December 1968
    Individual
    Officer
    2017-06-29 ~ 2018-06-11
    OF - Director → CIF 0
  • 12
    Mohan, Raju
    Pharma Research And Development born in November 1956
    Individual (4 offsprings)
    Officer
    2014-10-24 ~ 2016-09-26
    OF - Director → CIF 0
  • 13
    Tomkins, Judith
    Individual (10 offsprings)
    Officer
    2018-02-19 ~ 2020-10-02
    OF - Secretary → CIF 0
  • 14
    Carruthers, David, Dr.
    Director born in January 1981
    Individual (2 offsprings)
    Officer
    2019-08-27 ~ 2023-12-08
    OF - Director → CIF 0
parent relation
Company in focus

AKARNA THERAPEUTICS, LTD

Standard Industrial Classification
72110 - Research And Experimental Development On Biotechnology
Brief company account
Please be reminded the displayed account data is older than 4 years hence might not reflect current company status.
Par Value of Share
Class 2 ordinary share
0 GBP2014-10-24 ~ 2015-12-31
Class 1 ordinary share
0 GBP2014-10-24 ~ 2015-12-31
Nominal value of shares issued
Class 1 ordinary share
0 GBP2014-10-24 ~ 2015-12-31
Tangible fixed assets
692 GBP2015-12-31
Debtors
140,282 GBP2015-12-31
Cash at bank and in hand
398,278 GBP2015-12-31
Current Assets
538,560 GBP2015-12-31
Current liabilities
1,030,170 GBP2015-12-31
Net Current Assets/Liabilities
-491,610 GBP2015-12-31
Total Assets Less Current Liabilities
-490,918 GBP2015-12-31
Called-up share capital
22 GBP2015-12-31
Share premium account
1,625,653 GBP2015-12-31
Retained earnings
-2,116,593 GBP2015-12-31
Shareholder's fund
-490,918 GBP2015-12-31
Cost/valuation of tangible fixed assets
996 GBP2015-12-31
Depreciation expense of tangible fixed assets in the period
304 GBP2014-10-24 ~ 2015-12-31
Depreciation of tangible fixed assets
304 GBP2015-12-31
Number of shares allotted
Class 2 ordinary share
2,240,720 shares2015-12-31
Paid-up share capital
Class 2 ordinary share
15 GBP2015-12-31
Number of shares allotted
Class 1 ordinary share
1,002,329 shares2015-12-31
Value of shares allotted
Class 1 ordinary share
7 GBP2015-12-31
Number of shares issued
Class 1 ordinary share
1,002,329 shares2014-10-24 ~ 2015-12-31
  • AKARNA THERAPEUTICS, LTD
    Info
    Registered number 09278993
    Ground Floor Marlow International, Parkway, Marlow SL7 1YL
    Private Limited Company incorporated on 2014-10-24 (10 years 8 months). The company status is Active.
    The last date of confirmation statement was made at 2024-05-21
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

qrcode

Privacy notice

Terms and conditions

© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.